Browse drugs

…ably prevalent in the placebo group, with minimal increase with azithromycin treatment, suggesting that, regardless of the additional use of…

…hromycin vs discontinuation trial in COPD patients on long-term azithromycin prophylaxis to reduce exacerbations. We performed a trial sub-s…

…Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce c…

…cantly by treatment group (0.025 (95% CI 0.013 to 0.037) in the azithromycin group and 0.022 (95% CI 0.011 to 0.033) in placebo (p=0.688)). …

…ighest probability of being ranked most effective. Single-round azithromycin MDA was also associated with reduced odds of active yaws at fol…

…iption of antibiotics at any time point.Conclusions Intrapartum azithromycin prevents a variety of infections for birthing parents and infan…

…mycin on growth. Taken together, the results suggest that while azithromycin MDA reduces childhood mortality, it is unlikely to provide medi…

…s introduced, initially referring to TB resistant to isoniazid, rifampicin, and at least three of the six main classes of second line drug…

…lse negative due to the presence of the S91I gyrA mutation. Two azithromycin resistance marker false positive calls were identified due to t…

…Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic o…

…ycin Therapy) trial. This trial compares continuing vs stopping azithromycin therapy in patients with non-cystic fibrosis bronchiectasis. Th…

…lter RV-induced mRNA expression of TNF-α nor CCL20. Compared to azithromycin, the effects of EP395 on the BEC anti-viral and pro-inflammator…